of adult patients, and limited in follow-up. 5, 14 Although the first few studies reported complete success with no complications, the largest and most recent series created doubt regarding the true success rate of these implants, because a 23.8% complication rate was documented. 10 In general, we have considered these custom cranial implants to have high success rates as demonstrated in our recent publication examining risk factors of bone flap resorption following hemicraniectomy for pediatric traumatic brain injury. We found that age < 2.5 years old, hydrocephalus, an underlying cerebral contusion, and a comminuted skull fracture were all independent risk factors for bone flap resorption and that custom cranioplasties were successful in revision cranioplasty following bone flap resorption in 91.7% (11/12) of the cases. 1 In this current study, our goal was to identify whether either cranioplasty implant type, PEEK or HTR-PMI, was more successful than the other and to identify risk factors of custom cranial implant failure. 1 
methods

Patient Sample
We performed a retrospective cohort chart review to identify patients < 18 years old with cranial defects necessitating cranioplasty with an HTR-PMI or PEEK implant from January 1, 2000, through December 31, 2012, at Primary Children's Hospital, University of Utah. Standard cranial titanium plating systems were used for flap attachment in all patients. Drains were used sparingly, because of increased risk of infection and because one surgeon used them more often. This surgeon's preference was taken into account when we analyzed the different attending surgeons. Patients were excluded if craniosynostosis was the cause of their cranial defect, because these small cranial defects are distinct from the large frontotemporoparietal cranial defects typically seen after decompressive craniectomy, infected bone flaps, or cranial defects created from tumor resection involving the skull. Patients were also excluded if any other cranioplasty material was used besides PEEK or HTR-PMI or if the cranial defect was in the posterior fossa or an occipital location, because PEEK implants and HTR-PMIs are rarely indicated for these types of defects.
clinical Variables
Each variable was clearly defined a priori before chart abstraction to minimize measurement bias. Clinical variables examined included sex, race, age at implantation, and the cause of the cranial defect (including trauma, infected craniotomy flap, tumor-involved bone, and "other etiologies"). Other etiologies included defects secondary to craniosynostosis defect repair, decompressive hemicraniectomy for stroke, or craniotomies for vascular lesions or tumors that had subsequent bone flap resorption or were discarded. Other clinical variables studied included attending surgeon, involvement of the plastic surgery team, previous autologous cranioplasty failure, previous infection with the length of the quiescent period free of infection, previous PEEK or HTR-PMI cranioplasty failures, and length of follow-up.
Surgical Variables
The implant type used, PEEK or HTR-PMI, was the key variable to address the question of superiority between the 2 custom implant types. The extent of the gap between the implant and the native frontal bone was also measured on the postoperative CT head and subsequent CT scans. Any defect left along the floor of the temporal bone was not included in the measurement. At our hospital for most of the years of the study, CT scans were only acquired in the axial plane. The frontal area is easily visualized and measurable on an axial CT scan, and this allowed for a consistent measurement of the medial-lateral bone gap on serial imaging; however, the flap site of attachment for the temporal bone is vertical and therefore is less reliably measured while frequent large gaps are left in this noncosmetic region. Because of the observed trend in the association between increased bone gap width and implant failure, we examined it more closely. The data appeared to self-dichotomize with a cutoff of 6 mm, leading us to choose this cutoff point. We used an iterative process, with gap cutoffs close to 6 mm (i.e., 4 mm, 5 mm, 6 mm, 7 mm, and 8 mm), and 6 mm still appeared to be representative of the data.
Outcome
The primary outcome was implant failure, defined as any subsequent surgery performed to remove the cranioplasty implant, replacing it with a new implant because of infection, dislodgement, or unacceptable cosmesis. All chart reviews and data acquisition were in compliance with the regulations determined by the University of Utah Institutional Review Board and with the Health Insurance Portability and Accountability Act (HIPAA) of 1996.
Statistical analysis
All statistical analyses were conducted using SAS version 9.3 (SAS Institute). Each variable was compared with the outcome, using the chi-square test for categorical variables and the Student t-test for continuous variables. All variables were tested and found to be parametric. Any variables found to be significant (p < 0.05) or nearly significant (p < 0.10) were included in the multivariate analysis. Stepwise logistic regression was used to determine which of those variables were independently associated (p < 0.05) with implant failure.
results
Patient Sample
A total of 54 children were identified as having undergone 69 custom cranioplasties (50 in boys, 19 in girls; mean age 8.2 years). Each procedure was treated as an independent event for analysis of cranial defects with PEEK implants or HTR-PMIs from 2000 through 2012 at our institution. There were 15 implant failures for a failure rate of 21.7%.
In the vast majority of cranioplasty procedures, the patient had cranial defects from prior trauma (41 cases, 59.4%; Table 1 ). Previous tumor resections involving the bone and resulting in cranial defects only accounted for 6 implants (11.1%), while a previous infected flap accounted for 9 implants (16.7%). There were a total of 41 HTR-PMI implants (59.4%) and 28 PEEK implants (40.6%). The average postoperative bone gap was 3 mm (SD ± 2.3), and in 6 of 69 custom cranioplasty cases (8.7%) there was a bone gap > 6 mm. The plastic surgeons were involved in 22 cases (31.9%). Nine infections after implant placement (13.0%) were counted as implant failures, because the implants were then discarded. The median patient follow-up was 17.0 months (± 32.8 months). None of these patients were lost to follow-up.
univariate analysis
A univariate analysis was conducted to evaluate all of the variables and compare them with the outcome of implant failure (Table 2) . A large postoperative bone gap had a nonsignificant trend toward implant failure with a mean gap of 4.5 mm in failed cases versus 2.6 in successful implantations (p = 0.10). When dichotomized between those with a gap > 6 mm and those with a gap < 6 mm between the implant and the frontal bone, those with bone gaps ≥ 6 mm were more likely to experience implantation failure (p = 0.02). Unexpectedly, a prior failure of a PEEK or HTR-PMI implant was associated with a higher probability of implant success (p = 0.03). A shorter time from craniectomy or bone flap resorption to implantation had a near-significant association with implant failure (p = 0.08). Patient age, race, sex, reason for custom cranial implant, attending surgeon, plastic surgery involvement were not associated with implant failure according to univariate analysis (Table 2) , nor were a prior history of autologous cranioplasty, the presence of a previous infection, or the length of time since the infection (data not shown). Our main predictor of interest was the type of implant used (PEEK or HTR-PMI), and neither product had a statistically significant advantage over the other (p = 0.96).
multivariate analysis
Using multivariate logistic regression, we developed a predictive model. The significant variables on univariate analysis (bone gap > 6 mm and prior PEEK implant/HTR-PMI failure) were tested with the model, as were the nearsignificant variable (decreased time since the last implant failure) and the primary research question of implant type (PEEK vs HTR-PMI; Table 3 ). A bone gap between the implant and the native frontal bone (p = 0.03, OR 8.3, 95% CI 1.2-55.9) was found to be the only independent risk factor for implant failure.
implant type Selection (PeeK vs htr-Pmi)
We looked not only at the failure rate of each implant type but also at what factors influenced the choice of which implant type to use (PEEK or HTR-PMI; Table  4 ). According to the univariate analysis, PEEK implants were used more frequently when the mechanism of original need for cranioplasty was traumatic (p = 0.02), when there was posttraumatic hydrocephalus present (p = 0.01), or when there was a shorter time since the initial event or previous cranioplasty attempt (p = 0.004). In terms of surgeon preferences, one of the attending neurosurgeons was much more likely to choose HTR-PMIs, 2 others preferentially used PEEK, while 2 others split their preferences (p = 0.002). PEEK was used more commonly when plastic surgeons were involved in the case as co-surgeons (p = 0.01). The patient age, the complication rate (infection and CSF leak), and a postoperative bone gap > 6 mm were not associated with the type of implant chosen.
discussion
We present a retrospective cohort study of 54 pediatric patients who had 69 implantations of either PEEK or HTR-PMI custom cranial implants. The overall implant failure rate was 21.7%, and there was no association between implant type (PEEK vs HTR-PMI) and failure rate. Univariate analysis of risk factors showed that patients with a gap > 6 mm between the implant and the frontal bone were more likely to have an implant failure, while those patients with a prior custom cranioplasty failure (PEEK or HTR-PMI) were actually less likely to experience implant failure. Multivariate analysis of significant and near-significant univariate variables indicated that a bone gap of > 6 mm between the implant and the frontal bone was the only independent risk factor for implant failure. PEEK has been used for some time in orthopedic and spinal surgery. 11 It is stronger than bone and compares favorably with titanium in biomechanical testing yet does not have thermal conduction as a limitation.
7,11 However, PEEK does not integrate with the native bone flap through bony fusion and therefore must rely on a binding fibrotic reaction and tight approximation to the bone flap. 11 The literature regarding PEEK cranioplasties is scant, consisting of 3 small case series of 12, 6, and 4 patients, respectively, in addition to scattered case reports. 6, 8, 11 Although it is quite difficult to draw conclusions with these small numbers with limited follow-up, the combined complication rate is approximately 33%. Nevertheless, the reports highly recommend PEEK implants as a cranioplasty option when the native bone is unavailable, because of the reduced operative time and technical ease of placement.
6,8,11
Still, no long-term follow-up has been reported.
The HTR-PMI is composed of a nonresorbable porous polymer of several synthetic materials with specific surface properties of increased porosity and hydrophilic negative charge designed to encourage bony incorporation and growth while repelling bacterial infection. 14 The cranioplasty literature regarding HTR-PMIs is also small, but the material has been used extensively in dentoalveolar reconstructions for over 40 years. 10 Four HTR-PMI cranioplasty series consisted of < 20 patients each without long-term follow-up. No complications were reported in some series, and a rate of 18% was reported in one series. 4, 5, 10, 14 A more recent series of 21 patients reported a complication rate of almost 25%; prior infection, smoking, and diabetes were all not associated with increased complications. 10 
implant type
The total of 41 HTR-PMIs and 28 PEEK implants makes this the largest reported series of each type of cranioplasty implant in the literature. The primary question of this study was to determine which implant type was the most successful for repairing cranial defects. We found that these implants were essentially equivalent with respect to their success rates (p = 0.96). This is an impor- tant contribution since these two common implants have never been directly compared. The overall failure rate of 21.7% is consistent with the recent reports on HTR-PMI and PEEK cranioplasty implants.
10,11 time elapsed Between Previous cranioplasty attempt and New implant Surgery
The time elapsed between previous cranioplasty attempt and new implant surgery approached significance (p = 0.08) in the univariate analysis but was not significant in the multivariate analysis (p = 0.16). Although we did not find it to have an independent association with implant failure, this trend warrants further discussion. One hypothesis is that the shorter time between craniectomy or resorption and implant placement may be a reflection of more infections causing implant failures, as some literature suggests 13, 15 that early cranioplasty after craniectomy may predispose to infection. An alternative hypothesis is that the shorter interval may not permit the entire bone remodeling process to occur. This may hinder successful implant placement, because a bone gap may develop due to the native bone continuing to be resorbed and to remodel, thus precluding a tight native bone and implant fusion.
Prior Failure of PeeK or htr-Pmi and Prior infection
One important and interesting finding from this study is that prior PEEK or HTR-PMI implant failure was associated with subsequent implant success (p = 0.03); there were no implant failures for any of the 15 implants that were placed after a previous PEEK or HTR-PMI implant failure. Furthermore, previous infection did not predispose patients to an increased risk of failure or infection (p = 0.72). We are unsure why prior failure predisposed patients to successful subsequent reimplantation; however, our best hypothesis is that, after reimplantation, more time has passed since the initial injury (e.g., infection or trauma), and the surrounding native bone has had more time to complete its healing (i.e., further resorption). Therefore, increased subsequent bone gaps are less likely upon reimplantation, because the bone is more quiescent and not in active remodeling and thus is more favorable for healing with implantation. The ramifications of these findings are significant, as subsequent surgical salvage procedures are usually significantly less successful than the original attempts, especially in the setting of a previous infection. 3, 9, 12 This finding can give surgeons confidence in attempting a second custom PEEK or HTR-PMI implantation, even after a previous failure from infection.
Bone gap
We found that an increased bone gap > 6 mm was an independent risk factor for implant failure (OR 8.3, 95% CI 1.2-55.9, p = 0.03). The implant failure rate for a bone gap of > 6 mm was 66.7% versus 17.5% when the bone gap was < 6 mm. These findings are especially important in this surgical series, because bone gap width is a modifiable risk factor based on surgical technique. This suggests that taking the extra surgical time to achieve a near-perfect approximation of the native bone with the custom cranial implants may be critical to successful implantation. The majority of patients with a bone gap > 6 mm were 5 years of age and younger (4/6 patients, 66.7%). We have previously documented younger age as a risk factor for bone flap resorption after autologous cranioplasty. It seems logical that a bone gap in a younger child would be harder to integrate with a custom implant, because the head grows more rapidly in younger children compared with the head of a teenager or older child with near-complete head growth.
Surgeon Selection of implant type
It is interesting to note the fairly large number of significant variables that were associated with the use of PEEK implant or HTR-PMI as the custom cranial implant. Diverse factors including traumatic etiology, who was involved in surgery, time since previous cranioplasties, and presence of hydrocephalus were all statistically significant, illustrating the specific situations and personal preferences that highlight the need for further study. If further trials confirm our findings that the two implants have similar outcomes, surgeon preference will be an appropriate criterion for selecting the specific implant. limitations The principal limitation of this study is that it is a retrospective cohort study and not a prospective trial. Another limitation is that the small number of clinical events (15 failures) is a small sample size for the number of variables analyzed. Therefore, we recommend that our conclusions serve as hypothesis generators for further prospective study of the importance of eliminating bone gaps with custom cranial implantation and not as definitive guidelines.
conclusions
The pediatric patients in our study who underwent custom cranioplasty faced an implant failure rate of 21.7% with initial custom PEEK or HTR-PMI cranial implants. No significant difference was found in implant failure with either implant type (PEEK or HTR-PMI). Multivariate analysis of risk factors revealed that a bone gap > 6 mm was an independent risk factor for implant failure. We recommend that a tight approximation of the implant to the native bone be achieved in all custom cranial implant procedures to provide a greater opportunity for success. Fortunately, if custom cranioplasty with a PEEK implant or HTR-PMI fails, revision custom cranioplasty with a PEEK or HTR-PMI procedure appears to have an extremely high success rate.
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